These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 16816826

  • 21. Continuous combined hormone replacement therapy relieves climacteric symptoms and improves health-related quality of life in early postmenopausal women.
    Pitkin J, Smetnik VP, Vadász P, Mustonen M, Salminen K, Ylikangas S, Indivina 321 Study Group.
    Menopause Int; 2007 Sep; 13(3):116-23. PubMed ID: 17785037
    [Abstract] [Full Text] [Related]

  • 22. Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension.
    Karalis I, Beevers G, Beevers M, Lip G.
    Blood Press; 2005 Sep; 14(1):38-44. PubMed ID: 15823946
    [Abstract] [Full Text] [Related]

  • 23. A randomized study to compare the effectiveness, tolerability, and acceptability of two different transdermal estradiol replacement therapies. The Transdermal HRT Investigators Group.
    Int J Fertil Menopausal Stud; 1993 Sep; 38(1):5-11. PubMed ID: 8485612
    [Abstract] [Full Text] [Related]

  • 24. [The influence of the hormonal replacement therapy on conjunctival epithelium morphology among peri- and postmenopausal women].
    Okoń A, Jurowski P, Goś R.
    Klin Oczna; 2001 Sep; 103(4-6):183-6. PubMed ID: 11975014
    [Abstract] [Full Text] [Related]

  • 25. Hormone replacement therapy: one-year follow up of DNA damage.
    Casella M, Manfredi S, Andreassi MG, Vassalle C, Prontera C, Simi S, Maffei S.
    Mutat Res; 2005 Aug 01; 585(1-2):14-20. PubMed ID: 15996896
    [Abstract] [Full Text] [Related]

  • 26. Gradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: a randomized prospective study.
    Haimov-Kochman R, Barak-Glantz E, Arbel R, Leefsma M, Brzezinski A, Milwidsky A, Hochner-Celnikier D.
    Menopause; 2006 Aug 01; 13(3):370-6. PubMed ID: 16735933
    [Abstract] [Full Text] [Related]

  • 27. Sexually and well-being in early menopause. Effect of transdermal estradiol therapy.
    Rigano A, Rigano M, Cancellieri F, Pullè C.
    Panminerva Med; 2001 Jun 01; 43(2):115-8. PubMed ID: 11449182
    [Abstract] [Full Text] [Related]

  • 28. Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.
    Mattsson LA, Skouby S, Rees M, Heikkinen J, Kudela M, Stadnicki-Kolendo A, Mattila L, Salminen K, Vuorela A, Mustonen M, Indivina 321 Study Group.
    Menopause Int; 2007 Sep 01; 13(3):124-31. PubMed ID: 17785038
    [Abstract] [Full Text] [Related]

  • 29. [Transdermal estrogenic therapy in menopause].
    Nencioni T, Polvani F, Penotti M, Porcaro E, Barbieri Carones M.
    Minerva Endocrinol; 1989 Sep 01; 14(1):49-52. PubMed ID: 2543896
    [Abstract] [Full Text] [Related]

  • 30. Do different delivery systems of hormone therapy have different effects on psychological symptoms in surgically menopausal women? A randomized controlled trial.
    Baksu B, Baksu A, Göker N, Citak S.
    Maturitas; 2009 Feb 20; 62(2):140-5. PubMed ID: 19179026
    [Abstract] [Full Text] [Related]

  • 31. Comparison of a transdermal continuous combined and an interrupted progestogen HRT.
    Cameron ST, Glasier AF, Gebbie A, Dewart H, Baird DT.
    Maturitas; 2006 Jan 10; 53(1):19-26. PubMed ID: 16325020
    [Abstract] [Full Text] [Related]

  • 32. A comparison of transdermal and oral HRT for menopausal symptom control.
    Akhila V, Pratapkumar.
    Int J Fertil Womens Med; 2006 Jan 10; 51(2):64-9. PubMed ID: 16881381
    [Abstract] [Full Text] [Related]

  • 33. Bleeding profiles and effects on the endometrium for women using a novel combination of transdermal oestradiol and natural progesterone cream as part of a continuous combined hormone replacement regime.
    Vashisht A, Wadsworth F, Carey A, Carey B, Studd J.
    BJOG; 2005 Oct 10; 112(10):1402-6. PubMed ID: 16167944
    [Abstract] [Full Text] [Related]

  • 34. Factors associated with climacteric symptoms and the use of hormone replacement therapy.
    Stadberg E, Mattsson LA, Milsom I.
    Acta Obstet Gynecol Scand; 2000 Apr 10; 79(4):286-92. PubMed ID: 10746844
    [Abstract] [Full Text] [Related]

  • 35. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R, Lorenz V, Korak-Leiter M, Kager I, Sittl R.
    Clin Ther; 2007 Aug 10; 29(8):1591-606. PubMed ID: 17919542
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study.
    Ruiz AD, Daniels KR.
    Int J Pharm Compd; 2014 Aug 10; 18(1):70-7. PubMed ID: 24881343
    [Abstract] [Full Text] [Related]

  • 38. Effects of long-term transdermal hormone replacement therapy on the renin-angiotensin- aldosterone system, plasma bradykinin levels and blood pressure in normotensive postmenopausal women.
    Ichikawa A, Sumino H, Ogawa T, Ichikawa S, Nitta K.
    Geriatr Gerontol Int; 2008 Dec 10; 8(4):259-64. PubMed ID: 19149837
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.